Phase 3 COPD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have severe or very severe COPD (classified as GOLD stage 3 or 4)
- People who still experience significant breathlessness even after receiving the best available standard treatment
- People whose breathlessness is rated at level 3 or higher on a standard scale called the mMRC scale, meaning breathlessness that seriously limits daily activity
- People aged 18 or older who are considered legally and mentally capable of making their own decisions
- People who understand and speak Danish
- People who are able to give written informed consent to participate
- Women who could potentially become pregnant must have a negative pregnancy test before entering the trial
- Fertile people who are sexually active must agree to use reliable contraception (such as an IUD, contraceptive pill, implant, patch, vaginal ring, or depot injection) throughout the treatment period and for 4 weeks after finishing
Who may not be able to join:
- People who have had an active infection or a flare-up of their COPD within the last 30 days
- People who have been regularly using THC or CBD products within the last 30 days
- People whose life expectancy is estimated to be less than 3 months
- People currently taking certain medications that strongly affect the way the body processes drugs (specifically, strong inhibitors or inducers of enzymes called CYP3A4, CYP2C9, or CYP2C19 — confirm specific medications with the trial site)
- People with a significant medical or psychiatric condition that the trial doctor believes would put them at greater risk of harm during the study
- People with a current or past history of substance misuse that the trial doctor considers too risky for participation
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ole Hilberg, Prof., MD, Medical Department, Vejle Hospital
Phone: +45 79409055
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Difference in Numeric Rating Scale score of discomfort of daily breathlessness between active treatment and placebo; Difference in Numeric Rating Scale score of breathlessness interference of daily activities between active treatment and placebo; Correlation between breathlessness rated on a daily numeric rating scale in relation to amount of THC blood level of the active treatment period; Correlation between breathlessness interference of daily activities rated on a numeric rating scale in relation to amount of THC blood level of the active treatment period
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.